Mylan Execs Gave Themselves Raises and Hiked EpiPen Prices | NECN
National & International News
The day’s top national and international news

Mylan Execs Gave Themselves Raises and Hiked EpiPen Prices

The years 2010-2013 saw a succession of 10 percent price hikes

    processing...

    NEWSLETTERS

    AP
    FILE - Mylan EpiPen epinephrine auto-injector.

    EpiPen prices aren't the only thing to jump at Mylan. Executive salaries have also seen a stratospheric uptick, NBC News reported.

    Proxy filings show that from 2007 to 2015, Mylan CEO Heather Bresch's total compensation went from $2,453,456 to $18,931,068, a 671 percent increase. During the same period, the company raised EpiPen prices, with the average wholesale price going from $56.64 to $317.82, a 461 percent increase, according to data provided by Connecture.

    In 2007 the company bought the rights to EpiPen, a device used to provide emergency epinephrine to stop a potentially fatal allergic reaction and began raising its price. In 2008 and 2009, Mylan raised the price by 5 percent. At the end of 2009 it tried out a 19 percent hike. The years 2010-2013 saw a succession of 10 percent price hikes.

    And from the fourth quarter of 2013 to the second quarter of 2016, Mylan steadily raised EpiPen prices 15 percent every other quarter.